Condition
Diabetes (DM) clinical trials and research
As of November 12, 2026, Find a Trial lists 21 Diabetes (DM) clinical trials that are recruiting, at sites in 15 countries (most in United States (4), Taiwan (2), United Kingdom (2)). 2 were first registered in the last 30 days. By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 21Clinical trials
- 2New in 30 days
- 15Countries
Newest Diabetes (DM) clinical trials
All recruiting trials (21)
-
Continuous temperature monitoring of the feet with connected insoles and a smartphone app in adults with diabetes at high risk
This trial tests whether the Solsius SelfCare system can reliably flag pre-ulcer foot changes in adults with diabetes by detecting temperature differences between feet for at least two consecutive days.
-
RIGHTEST iFree 2 CGM system for better diabetes control in adults on insulin
A real-time CGM system is tested to see if it improves blood sugar control for adults with type 1 or type 2 diabetes on insulin, compared with finger-stick monitoring.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
How GLP-1 meds affect resistance training in adults with obesity/diabetes
This study tests whether adults taking a GLP-1 receptor agonist can better preserve or gain muscle when they do resistance training.
-
Next-Generation AID Algorithm for Type 1 Diabetes using Omnipod system
This study tests a new automated insulin delivery algorithm with Omnipod M/S in people with type 1 diabetes to see if it can safely support glucose control.
-
Three-stage CGM integration program for older adults with insulin-dependent diabetes
A program with three CGM-focused training sessions is being tested to see if it helps older adults using insulin wear CGMs more and manage their glucose better compared with standard CGM training.
-
Community health worker-led integrated care for hypertension and diabetes in Namobuddha
This project tests if trained community health workers can improve blood pressure and blood sugar care for adults with hypertension and diabetes in Namobuddha Municipality, Nepal.
-
HbA1c accuracy in people with inflammatory arthritis on sulfasalazine
This study tests whether HbA1c reliably reflects blood glucose in adults with inflammatory arthritis who are treated with sulfasalazine, by comparing it to continuous glucose monitoring.
-
New-generation diabetes medicines and the onset of diabetic retinopathy
This study will test whether newer diabetes medicines (SGLT2 and DPP‑4 inhibitors) can delay diabetic retinopathy in people with type 2 diabetes who've had the disease for more than five years and have been on diabetes medications for 2–3 years.
-
NTU JO-SMART Program for Obesity and Knee Osteoarthritis
A program that combines AI-guided community exercise with continuous glucose monitoring to help people who are overweight and have knee OA see if it improves blood sugar and joint health.
-
How heart rate affects heart pumping strength in people with heart failure and diabetes
Researchers will test whether abnormal metabolism in the heart and skeletal muscle explains why people with heart failure, especially those with diabetes, do not increase heart pumping effectively when their heart rate rises.
-
Dietitian-led follow-up versus day-hospital endocrinology care for improving blood sugar in type 2 diabetes
This project will test whether follow-up by a dietitian-nutritionist or care in a day hospital leads to better three-month HbA1c in people with type 2 diabetes who are on insulin and have poor blood sugar control.
-
EMR prompts in primary care to help prevent prediabetes from becoming diabetes
This project will test whether electronic medical record prompts for doctors in primary care help adults with prediabetes avoid developing diabetes.
-
Cardio-renal outcomes with SGLT2 inhibitors in CKD patients with HFpEF
This project will try to see if people with stage 3–4 CKD and HFpEF who take SGLT2 inhibitors have better heart and kidney outcomes than similar patients who do not.
-
How alpha‑cell signals change beta‑cell insulin release during insulin resistance
This project tests whether blocking GLP‑1 signaling changes how alpha‑cell hormones affect insulin release in non‑diabetic adults with and without obesity, before and after short‑term insulin resistance.
-
Digital twins to classify mental health patterns in adults with diabetes
This project will try to create 'digital twin' profiles that combine glucose, mood, and behavior data to track mental health patterns in adults with diabetes.
-
Intravenous arginine to help treat diabetic ketoacidosis in people with type 2 diabetes
This study tests whether a single IV dose of arginine given early in DKA can safely boost your own insulin and help adults with ketone-prone type 2 diabetes recover faster.
-
Adding proprioceptive neuromuscular facilitation to Otago exercises to reduce fall risk in people with type 2 diabetes
This tests whether adding PNF to standard Otago balance and strength exercises helps people aged 50–75 with type 2 diabetes and peripheral neuropathy reduce their risk of falling.
-
How SGLT2 inhibitors affect kidneys and metabolism in people over 65
This project will test whether starting SGLT2 inhibitor treatment changes clinical and lab measures in people aged 65 and older with diabetes, heart disease, or kidney problems.
-
NIRS-OCT imaging to find vulnerable coronary plaques in people with diabetes
This project will test whether a new combined NIRS-OCT index (maxLCBI4mm/FCTmin) can identify vulnerable coronary plaques in adults with diabetes who are undergoing coronary OCT.
Related topics
Quick answers
How many Diabetes (DM) clinical trials are recruiting right now?
21, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 15 countries. The most sites are in United States (4 trials), Taiwan (2 trials), United Kingdom (2 trials), Germany (2 trials), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.